Save 20% on all 25 µl vials
Discount code: "ATLAS20YEARS"
Valid through 2026.
Use code at checkout on atlasantibodies.com
What Makes our Antibodies Different?
1) High Affinity, High Specificity
Made with unique recombinant PrEST antigens designed for maximum specificity and minimal cross-reactivity.
2) Real Human Tissues
Validated by standardized IHC on 44 normal and 20 cancer tissues.
3) Enhanced Validation
Many of our antibodies also pass enhanced validation as an extra step.
4) Unmatched Data Transparency
Everyproduct is linked to full expression and performance data in the Human Protein Atlas.
5) Characterization and Validation
Validated in IHC, WB, ICC-IF and ChIP in cells and tissue.
6) Clone Selection
Best clones chosen from many ELISA-positive supernatants. subcloned and expanded.
7) Isotyping
PrecisA Monoclonal are isotyped for multiplexing with isotype-specific secondaries.
8) Epitope Mapping
Mapped with overlapping peptide arrays to select clones with non-overlapping epitopes.
Designed for Discovery. Powered by Data.
Whether you work in oncology, neuroscience, pathology, or basic research our antibodies provide the depth, consistency, and validation you need. Each antibody is connected to extensive expression profiles, tissue-level staining, and subcellular localization data through the Human Protein Atlas — with complete transparency.
Proven in-house. Validated by Science.
Immunohistochemistry
Research Spotlight: Reducing uncertainty in drug development: a Q&A with Thomas Helleday
Read more
Immunohistochemistry
Research Spotlight: How Spatial Proteomics Unlocked DHCR7 as a Target in Early Ovarian Cancer
Read more
Glioma
New Insights into Malignant Transformation in IDH-Mutant Glioma
Discover how researchers used a novel patient-derived 3D cell model and an Atlas Antibodies' anti-ATRX antibody to uncover new insights into how IDH-mutant gliomas turn malignant, opening doors for new therapeutic targets.
Read more
Our anti-P2RY12 and Alzheimer's disease
Read more
43 Polyclonals to explore intricacies of the stomach
Read more
Atlas Antibodies supports new MolBoolean protein analysis
Read more
